Loss of O6-methylguanine-DNA methyltransferase confers collateral sensitivity to carmustine in topoisomerase II-mediated doxorubicin resistant triple negative breast cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Loss of O6-methylguanine-DNA methyltransferase confers collateral sensitivity to carmustine in topoisomerase II-mediated doxorubicin resistant triple negative breast cancer cells

Published:2013-01 Issue:2 Volume:85 Page:186-196
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Raguz Selina,Adams Caroline,Masrour Nahal,Rasul Sabeena,Papoutsoglou Panagiotis,Hu Yunhui,Cazzanelli Giulia,Zhou Yuan,Patel Naina,Coombes Charles,Yagüe Ernesto

Funder

Institute of Clinical Sciences

Breast Cancer Research Trust

Cancer Research UK

China Scholarship Council

Experimental Cancer Medicine Centre Network

Bodossaki Foundation

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference59 articles.

1. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

2. Tamoxifen (“Nolvadex”): a review;Clemons;Cancer Treat Rev,2002

3. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug;Capdeville;Nat Rev Drug Discov,2002

4. Is resistance useless? multidrug resistance and collateral sensitivity;Hall;Trends Pharmacol Sci,2009

5. Collateral sensitivity as a strategy against cancer multidrug resistance;Pluchino;Drug Resist Updat,2012

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single Live Cell Imaging of Multidrug Resistance Using Silver Ultrasmall Nanoparticles as Biosensing Probes in Triple-Negative Breast Cancer Cells;ACS Applied Bio Materials;2023-10-16

2. Adaptive resistance is not responsible for long-term drug resistance in a cellular model of triple negative breast cancer;Gene;2023-01

3. Targeted Therapy and Personalized Medicine;Therapeutic Approaches in Cancer Treatment;2023

4. An integrated multi-omics analysis of topoisomerase family in pan-cancer: Friend or foe?;PLOS ONE;2022-10-26

5. Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cells;Cancer Chemotherapy and Pharmacology;2022-02-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3